SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-19-000111
Filing Date
2019-11-12
Accepted
2019-11-12 16:28:10
Documents
106
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beigene2019q310-q.htm   iXBRL 10-Q 2567260
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 12016
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 12041
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 10388
  Complete submission text file 0001651308-19-000111.txt   10088932

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20190930.xsd EX-101.SCH 71299
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20190930_cal.xml EX-101.CAL 119296
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20190930_def.xml EX-101.DEF 315955
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20190930_lab.xml EX-101.LAB 825191
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20190930_pre.xml EX-101.PRE 514569
53 EXTRACTED XBRL INSTANCE DOCUMENT beigene2019q310-q_htm.xml XML 1685983
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 191209949
SIC: 2834 Pharmaceutical Preparations